Stig Lenhoff

Stig Lenhoff

UNVERIFIED PROFILE

Are you Stig Lenhoff?   Register this Author

Register author
Stig Lenhoff

Stig Lenhoff

Publications by authors named "Stig Lenhoff"

Are you Stig Lenhoff?   Register this Author

41Publications

547Reads

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML.

Leuk Lymphoma 2018 Aug 2:1-9. Epub 2018 Aug 2.

a Department of Clinical Chemistry and Transfusion Medicine , Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg , Sweden.

View Article
August 2018

Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.

Leuk Res Rep 2015 17;4(2):72-5. Epub 2015 Oct 17.

Department of Hematology and Vascular Disorders, Skåne University Hospital, 22185 Lund, Sweden ; Department of Molecular Medicine and Gene Therapy, Sölvegatan 17, BMC A12, Lund University, 22184 Lund, Sweden.

View Article
December 2015

Being a haematopoietic stem cell donor for a sick sibling: Adult donors' experiences prior to donation.

Eur J Oncol Nurs 2015 Oct 23;19(5):529-35. Epub 2015 Mar 23.

Faculty of Health and Society, Malmö University, S-205 06 Malmö, Sweden. Electronic address:

View Article
October 2015

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Nat Commun 2015 May 26;6:7213. Epub 2015 May 26.

1] Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13, SE-221 84 Lund, Sweden [2] Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Akutgatan 8, SE-221 85 Lund, Sweden [3] Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article
May 2015

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

J Neurol Neurosurg Psychiatry 2014 Oct 19;85(10):1116-21. Epub 2014 Feb 19.

Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.

View Article
October 2014

Having a sibling as donor: patients' experiences immediately before allogeneic hematopoietic stem cell transplantation.

Eur J Oncol Nurs 2014 Aug 8;18(4):436-42. Epub 2014 Apr 8.

Faculty of Health and Society, Malmö University, S-205 06 Malmö, Sweden. Electronic address:

View Article
August 2014

Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma.

Cytometry B Clin Cytom 2010 Sep 28;78(5):338-47. Epub 2010 Apr 28.

Department of Haematology, Medical Center and Aalborg Hospital Science and Innovation Center (AHSIC), Aarhus University Hospital, Aalborg, Denmark.

View Article
September 2010

Serum calcium is an independent predictor of quality of life in multiple myeloma.

Eur J Haematol 2007 Jan 13;78(1):29-34. Epub 2006 Oct 13.

Department of Haematology, Faculty Division, Medical Clinic, Ullevål University Hospital, University of Oslo, Oslo, Norway.

View Article
January 2007

Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.

Eur J Haematol 2006 Nov 23;77(5):416-24. Epub 2006 Aug 23.

Department of Haematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

View Article
November 2006

Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.

Eur J Haematol 2005 Oct;75(4):293-8

Department of Haematology and Faculty Division, Ullevål University Hospital, 0407 Oslo, Norway.

View Article
October 2005

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.

Haematologica 2004 Feb;89(2):174-82

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article
February 2004

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.

Blood 2002 Dec 18;100(12):3925-9. Epub 2002 Jul 18.

Institute of Cancer Research and Molecular Biology, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article
December 2002

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy.

Br J Haematol 2002 Dec;119(3):672-6

Department of IMPI, Division of Pathology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

View Article
December 2002